SOTERA HEALTH COMPANY Net Income
SOTERA HEALTH COMPANY (SHC) reported Net Income of $53.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for the quarter ending 2026-06-30 was $53.64M, a 573.74% increase year-over-year.
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for the quarter ending 2026-03-31 was $26.59M.
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for the quarter ending 2025-12-31 was $34.85M, a 182.78% increase year-over-year.
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for the quarter ending 2025-09-30 was $48.40M, a 184.74% increase year-over-year.
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for fiscal 2020 was -$38.62M.
- SOTERA HEALTH COMPANY net income (loss) attributable to parent for fiscal 2019 was -$20.85M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $53.64M 10-Q · filed 2026-08-06 | $80.23M 10-Q · filed 2026-08-06 | $115.08M derived: sum of 3 quarters · filed 2026-08-06 | $163.48M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $26.59M 10-Q · filed 2026-05-05 | $61.44M derived: sum of 2 quarters · filed 2026-05-05 | $109.84M derived: sum of 3 quarters · filed 2026-05-05 | $117.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $34.85M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $83.25M derived: sum of 2 quarters · filed 2026-04-08 | $91.21M derived: sum of 3 quarters · filed 2026-08-06 | $77.95M DEF 14A · filed 2026-04-08 | |
| 2025-09-30 | $48.40M 10-Q · filed 2025-11-04 | $56.36M derived: sum of 2 quarters · filed 2026-08-06 | $43.10M 10-Q · filed 2025-11-04 | $55.42M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $7.96M 10-Q · filed 2026-08-06 | -$5.30M 10-Q · filed 2026-08-06 | $7.03M derived: sum of 3 quarters · filed 2026-08-06 | $24.02M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$13.26M 10-Q · filed 2026-05-05 | -$937.00K derived: sum of 2 quarters · filed 2026-05-05 | $16.06M derived: sum of 3 quarters · filed 2026-05-05 | $24.82M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $12.32M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $29.32M derived: sum of 2 quarters · filed 2026-04-08 | $38.08M derived: sum of 3 quarters · filed 2026-04-08 | $44.40M DEF 14A · filed 2026-04-08 | |
| 2024-09-30 | $17.00M 10-Q · filed 2025-11-04 | $25.75M derived: sum of 2 quarters · filed 2025-11-04 | $32.08M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $8.75M 10-Q · filed 2025-08-08 | $15.08M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $38.68M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $25.02M derived: sum of 2 quarters · filed 2026-04-08 | $48.53M derived: sum of 3 quarters · filed 2026-04-08 | $51.38M DEF 14A · filed 2026-04-08 | |
| 2023-09-30 | -$13.66M 10-Q · filed 2024-11-05 | $9.85M derived: sum of 2 quarters · filed 2024-11-05 | $12.70M 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $23.51M 10-Q · filed 2024-08-05 | $26.36M 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | -$408.00M DEF 14A · filed 2026-04-08 | -$382.91M derived: sum of 2 quarters · filed 2026-04-08 | -$352.49M derived: sum of 3 quarters · filed 2026-04-08 | -$233.57M DEF 14A · filed 2026-04-08 | |
| 2022-09-30 | $25.09M 10-Q · filed 2023-11-01 | $55.51M derived: sum of 2 quarters · filed 2023-11-01 | $86.15M 10-Q · filed 2023-11-01 | $121.45M derived: sum of 4 quarters · filed 2026-04-08 | |
| 2022-06-30 | $30.42M 10-Q · filed 2023-08-03 | $61.06M 10-Q · filed 2023-08-03 | $96.36M derived: sum of 3 quarters · filed 2026-04-08 | $123.80M derived: sum of 4 quarters · filed 2026-04-08 | |
| 2022-03-31 | $30.64M 10-Q · filed 2022-05-05 | $65.94M derived: sum of 2 quarters · filed 2026-04-08 | $93.38M derived: sum of 3 quarters · filed 2026-04-08 | $135.98M derived: sum of 4 quarters · filed 2026-04-08 | |
| 2021-12-31 | $35.30M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $62.74M derived: sum of 2 quarters · filed 2026-04-08 | $105.34M derived: sum of 3 quarters · filed 2026-04-08 | $116.18M DEF 14A · filed 2026-04-08 | $116.88M 10-K · filed 2022-03-01 |
| 2021-09-30 | $27.44M 10-Q · filed 2022-11-02 | $70.04M derived: sum of 2 quarters · filed 2022-11-02 | $80.89M 10-Q · filed 2022-11-02 | $37.20M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $42.60M 10-Q · filed 2022-08-04 | $53.44M 10-Q · filed 2022-08-04 | $9.76M derived: sum of 3 quarters · filed 2023-02-28 | $9.77M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $10.84M 10-Q · filed 2022-05-05 | -$32.84M derived: sum of 2 quarters · filed 2023-02-28 | -$32.83M derived: sum of 3 quarters · filed 2023-02-28 | -$25.81M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$43.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$43.67M derived: sum of 2 quarters · filed 2023-02-28 | -$36.65M derived: sum of 3 quarters · filed 2023-02-28 | -$38.62M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $10.00K 10-Q · filed 2021-11-10 | $7.03M derived: sum of 2 quarters · filed 2021-11-10 | $5.06M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $7.02M 10-Q · filed 2021-08-12 | $5.05M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$1.96M 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$20.85M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |